ANVS (Annovis Bio) Net Profit

ANVS (Annovis Bio Inc) - company brandmark

Annovis Bio, Inc. (ANVS) assets are protected by the humanitarian status of medicine and US jurisdiction. On GURU.Markets, the company's financial summary demonstrates a trend where -0.05 determines the latest valuation metric. Capitalization growth is based on patent scalability, while ultimate success relies on the effectiveness of buprenorphine in treating Alzheimer's and Parkinson's diseases by reducing toxic protein levels.

ANVS - annovisbio.com Company Net Income over the range 07/04/2022 - 11/01/2026

Comprehensive metric breakdowns and analytics for Annovis Bio (ANVS)

- stock value and consensus price forecast:
Market Price Annovis Bio Corporation|ANVS - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Annovis Bio Corporation|ANVS - Total Company Value
- book capitalization data:
Equity per Share Annovis Bio|ANVS - Company Book Value|Capitalization to Book Value Ratio annovisbio.com|ANVS - Aggregate Company Assets
- debt and liquidity details:
Debt to Capital Annovis Bio, Inc.|ANVS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Annovis Bio Inc|ANVS - Company Aggregate Debts|Debts to Net Assets Annovis Bio Corporation|ANVS - Company Long-Term Debt|Short-Term Debt Volume Annovis Bio|Intermediate Coverage Ratio annovisbio.com
- earnings and market ratios statistics:
ANVS - Net Profit
Fundamental valuation:ANVS - Annovis Bio Corporation
Signature product of Annovis Bio Inc

To find a balance between asset quality and business valuation, it is essential for investors to track daily net income, which captures the final financial result after all expenses. For Annovis Bio, Inc. (ANVS), this metric reflects the efficiency of managing costs for chemical raw materials and contract laboratories, clearly demonstrating the company's net balance.

Main competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Company Net Income Axsome Therapeutics, Inc. (AXSM)|ACADIA Pharma - Company Profit|Company Net Income Xenon Pharmaceuticals Inc XENE|VKTX: Company Profit|SUPN - Company Net Income|Company Net Income catalystpharma.com|DNLI (Denali Therapeutics Inc.) - Net Income|HRMY (Harmony Biosciences Inc) - Company Net Income|BHVN (Biohaven Pharmaceutical) - Net Profit|Amylyx Corp (AMLX) - Net Financial Result|Company Net Income Trevi Therapeutics (TRVI)|Net Financial Result praxismedicines.com|Anavex Life Sciences Corp. - Net Income|Final Profit CBLL|Prothena Biosciences - Net Profit|ALEC: Company Net Income|ANNX: Net Profit|OMER - Net Financial Result|Company Net Income Neurogene|Company Net Income AC Immune S.A. ACIU|Net Income VYGR (Voyager Pharma)|NMRA (Neumora Corp) - Final Profit|Net Profit SCLX (Scilex Holding Company)|Net Financial Result tevogen.com (TVGN)|ACOG - Company Net Income|CGTX (cogrx.com) - Company Profit|IKT: Net Profit|Net Income Cassava Pharma|Net Income ASRT|Coya (COYA) - Net Financial Result|Net Profit VTGN|Net Profit ovidrx.com (OVID)|Company Net Income Acumen Pharma ABOS|CRVO: Company Profit|ATHE: Net Income|CLNN: Company Net Income|pepgen.com (PEPG) - Company Net Income|JUNS - Net Financial Result|Company Net Income Relmada|Company Profit GRCE (Grace Tx)|Net Profit AIFF|KLTO - Company Net Income|NeuroSense Therapeutics Ltd. - Net Income|Net Profit Reviva Pharmaceuticals Holdings Inc. RVPH|MTVA - Company Net Income|Final Profit NRXS (NeurAxis Inc)|heliusmedical.com (HSDT) - Company Net Income|Company Net Income Passage Bio (PASG)|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Net Profit Minerva Neurosciences Inc|Company Net Income Athira (ATHA)|Addex - Company Profit|Company Net Income Alzamend Neuro ALZN|CYCN: Company Profit|PTIX - Company Net Income|Company Net Income Pasithea Therapeutics|CRGT (cortigent.com) - Net Income|ATXI (Avenue Therapeutics Inc) - Company Net Income|BCLI (Brainstorm Cell) - Net Profit|caratherapeutics.com (CARA) - Net Financial Result|Company Net Income Chromocell Therapeutics Corp. (CHRO)|Net Financial Result eliemtx.com|Intra-Cellular Therapies, Inc. - Net Income|Final Profit LBPH|Marinus Pharmaceuticals - Net Profit|NKGN: Company Net Income|NRBO: Net Profit|SAGE - Net Financial Result|Company Net Income Neurotrope|Company Net Income Trevena Inc TRVN|Net Income VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Final Profit|Net Profit CERE (Cerevel Therapeutics, Inc.)